1832 Asset Management
CSCI

1832 Asset Management’s COSCIENS Biopharma Inc. Common Stock CSCI Stock Holding History

1832 Asset Management’s Portfolio CSCI Stock Details CSCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-2,360
Closed -$10.4K – 935
2024
Q2 		$10.4K Buy
+2,360
New +$18K ﹤0.01% 767

Other funds holding CSCI

National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $140B AUM 46.34% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $32.7B AUM 35.71% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
TC
Truvestments Capital Sarasota, Florida $673M AUM 55.24% 1-Year Est. Return
PCMC
Planning Capital Management Corporation Paoli, Pennsylvania $151M AUM 30.62% 1-Year Est. Return
DB
Danske Bank Copenhagen K, Denmark $50.6B AUM 42.84% 1-Year Est. Return

1832 Asset Management's CSCI Position: Q3 2024 in Review

1832 Asset Management sold out of COSCIENS Biopharma Inc. Common Stock (CSCI) in Q3 2024, closing a stake of 2,360 shares — an estimated $10.4K sold.

1832 Asset Management first reported a position in CSCI in Q2 2024 and held it in 1 quarter. The position peaked at $10.4K in Q2 2024. 9 funds tracked by Wall St. Rank hold CSCI as of Q3 2024.

  • 1832 Asset Management reported no remaining COSCIENS Biopharma Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • 1832 Asset Management sold 2,360 COSCIENS Biopharma Inc. Common Stock shares in Q3 2024, an estimated $10.4K.
  • 1832 Asset Management first reported a position in COSCIENS Biopharma Inc. Common Stock in Q2 2024 and held it in 1 quarter.
  • 1832 Asset Management's COSCIENS Biopharma Inc. Common Stock position peaked at $10.4K in Q2 2024.
  • 9 funds tracked by Wall St. Rank held COSCIENS Biopharma Inc. Common Stock as of Q3 2024.

Based on 1832 Asset Management's 13F filing for Q3 2024, filed 13 Nov 2024.